73
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Cell Lines and Transgenic Mice Expressing a Matrix Metalloproteinase-9 Promoter-Driven Reporter Gene: Potential for Assay of Ultraviolet Light Effects and Light-Inhibiting Compounds

, , , &
Pages 383-397 | Published online: 10 Oct 2008

REFERENCES

  • Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000; 14(17): 2123–2133.
  • Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000; 20(12): 1681–1689.
  • Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002; 21(1): 1–14.
  • Chintala SK, Zhang X, Austin J, Fini ME. Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem 2002; 277(49): 47461–47468.
  • Mandal M, Mandal A, Das S, Chakraborti T, Sajal C. Clinical implications of matrix metalloproteinases. Mol Cell Biochem. 2003; 252(1–2):305–329.
  • Sellebjerg F, Sorensen TL. Chemokines and matrix metalloproteinase-9 inleukocyte recruitment to the central nervous system. Brain Res Bull 2003; 61(3): 347–355.
  • Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005; 9(2): 267–285.
  • McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001; 13(5):534–540.
  • Mohan R, Chintala SK, Jung JC, Villar WV, McCabe F, Russo LA, Lee Y, McCarthy BE, Wollenberg KR, Jester JV, Wang M, Welgus HG, Shipley JM, Senior RM, Fini ME. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem 2002; 277(3): 2065–2072.
  • Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463–516.
  • Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. 2004; 16(5): 558–564.
  • Fini ME, Cook JR, Mohan R, Brinckerhoff CE. Regulation of matrix metalloproteinase gene expression. In: Parks W, Mecham R, eds. Matrix Metalloproteinases. Academic Press; 1998.
  • Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K. High expression of 92-kDa type IV collagenase (gelatinase) in the osteoclast lineage during mouse development. Ann N Y Acad Sci 1994; 732: 472–475.
  • Reponen P, Leivo I, Sahlberg C, Apte SS, Olsen BR, Thesleff I, Tryggvason K. 92-kDa type IV collagenase and TIMP-3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation. Dev Dyn 1995; 202(4): 388–396.
  • Canete-Soler R, Gui YH, Linask KK, Muschel RJ. Developmental expression of MMP-9 (gelatinase B) mRNA in mouse embryos. Dev Dyn 1995; 204(1): 30–40.
  • Canete-Soler R, Gui YH, Linask KK, Muschel RJ. MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization. Brain Res Dev Brain Res 1995; 88(1): 37–52.
  • Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 2002; 37(6): 375–536.
  • Liu K, Wahlberg P, Ny T. Coordinated and cell-specific regulation of membrane type matrix metalloproteinase 1 (MT1-MMP) and its substrate matrix metalloproteinase 2 (MMP-2) by physiological signals during follicular development and ovulation. Endocrinology. 1998; 139(11): 4735–4738.
  • Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y, Muschel RJ. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 2000; 157(6): 1777–1783.
  • Jarrousse F, Boisnic S, Branchet MC, Beranger JY, Godeau G, Breton L, Bernard BA, Mahe YF. Identification of clustered cells in human hair follicle responsible for MMP-9 gelatinolytic activity: consequences for the regulation of hair growth. Int J Dermatol 2001; 40(6): 385–392.
  • Matsubara M, Zieske JD, Fini ME. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 1991; 32(13): 3221–3237.
  • Matsubara M, Girard MT, Kublin CL, Cintron C, Fini ME. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev Biol 1991; 147(2): 425–439.
  • Oikarinen A, Kylmaniemi M, Autio-Harmainen H, Autio P, Salo T. Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol 1993; 101(2): 205–210.
  • Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H, Larjava H. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 1994; 70(2): 176–82.
  • Fini ME, Girard MT, Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol Suppl 1992; (202):26–33.
  • Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993; 101(1): 64–68.
  • Fini ME, Parks WC, Rinehart WB, Girard MT, Matsubara M, Cook JR, West-Mays JA, Sadow PM, Burgeson RE, Jeffrey JJ, Raizman MB, Krueger RR, Zieske JD. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol 1996; 149(4): 1287–1302.
  • Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996 Nov; 107(5):743–748.
  • Herouy Y, May AE, Pornschlegel G, Stetter C, Grenz H, Preissner KT, Schopf E, Norgauer J, Vanscheidt W. Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: Implications for venous ulcer formation. J Invest Dermatol 1998; 111(5): 822–827.
  • Chintala SK, Wang N, Diskin S, Mattox L, Kagemann M, Fini ME, Schuman JS. Matrix Metalloproteinase gelatinase B (MMP-9) is associated with leaking glaucoma filtering blebs. Experimental Eye Res 2005; 81: 429–436.
  • Pflugfelder SC, Farley W, Luo L, Chen LZ, de Paiva CS, Olmos LC, Li D-Q, Fini ME. Matrix Metalloproteinase-9 (MMP-9) knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol 2005; 166: 61–71.
  • Diffey BL. What is light? Photodermatol Photoimmunol Photomed 2002; 18:68–74.
  • Schade N, Esser C, Krutmann J. Ultraviolet B radiation-induced immunosuppression: molecular mechanisms and cellular alterations. Photochem Photobiol Sci 2005; 4(9): 699–708.
  • Young AR. Cumulative effects of ultraviolet radiation on the skin: cancer and photoaging. Semin Dermatol 1990; 9(1): 25–31.
  • Fisher MS, Kripke ML. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Bull World Health Organ 2002; 80(11): 908–912.
  • Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, Voorhees JJ. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138(11): 1462–1470.
  • Kozak I, Klisenbauer D, Juhas T. UV-B induced production of MMP-2 and MMP-9 in human corneal cells. Physiol Res. 2003; 52(2): 229–234.
  • Inomata S, Matsunaga Y, Amano S, Takada K, Kobayashi K, Tsunenaga M, Nishiyama T, Kohno Y, Fukuda M. Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol 2003; 120(1): 128–134.
  • Patroi I, Annessi G, Girolomoni G. Mid-dermal elastolysis: a clinical, histologic, and immunohistochemical study of 11 patients. J Am Acad Dermatol 2003; 48(6): 846–851.
  • Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8(2): 395–405.
  • Fini ME, Bartlett JD, Matsubara M, Rinehart WB, Mody M, Girard MT, Rainville M. The rabbit gene for 92 kDa matrix metalloproteinase: role of AP1 and AP2 in cell type-specific transcription. J Biol Chem 1994; 269: 28620–28628.
  • Surgucheva IG, Sivak JM, Fini ME, Palazzo RE, Surgucheva AP. Effect of gamma-synuclein over-expression on matrix metalloproteinases in retinoblastoma Y79 cells. Arch Biochem Biophys 2003; 410(1): 167–176.
  • Sivak JM, Mohan R, Rinehart WB, Xu PX, Maas RL, Fini ME. Pax-6 expression and activity are induced in the re-epithelializing cornea and control activity of the transcriptional promoter for matrix metalloproteinase gelatinase B. Dev Biol 2000; 222: 41–54.
  • Mohan R, Rinehart WB, Bargagna-Mohan P, Fini ME. Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling. J Biol Chem 1998; 273(40): 25903–25914.
  • Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, Raizman MB, Fini ME. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 2000; 275(14): 10405–10412.
  • Johnson C, Sung HJ, Lessner SM, Fini ME, Galis ZS. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. Circ Res 2004; 94(2): 262–268.
  • Mukherjee R, Mingoia JT, Bruce JA, Austin JS, Stroud RE, Escobar GP, McClister DM, Allen CM, Alfonso-Jaume MA, Fini ME, Lovettpinale FG. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription following myocardial infarction. Am J Physiol Heart Circ Physiol 2006; Jun 9; [Epub ahead of print].
  • Bargagna-Mohan P, Strissel KJ, Fini ME. Regulation of gelatinase B production in corneal cells is independent of autocrine IL-1alpha. Invest Ophthalmol Vis Sci 1999; 40(3): 784–789.
  • Niederkorn JY, Meyer DR, Ubelaker JE, Martin JH. Ultrastructural and immunohistological characterization of the SIRC corneal cell line. In Vitro Cell Dev Biol 1990; 26: 923–930.
  • West-Mays JA, Sivak JM, Papagiotas SP, Kim J, Nottoli T, Williams T, Fini ME. Positive influence of AP-2alpha transcription factor on cadherin gene expression and differentiation of the ocular surface. Differentiation 2003; 71: 206–216.
  • Girard MT, Matsubara M, Fini ME. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci 1991; 32(9): 2441–2454.
  • Tong L, Corrales RM, Chen Z, Villarreal AL, De Paiva CS, Beuerman R, Li DQ, Pflugfelder SC. Expression and regulation of cornified envelope proteins in human corneal epithelium. Invest Ophthalmol Vis Sci 2006; 47(5): 1938–1946.
  • Linsenmayer TF, Cai CX, Millholland JM, Beazley KE, Fitch JM. Nuclear ferritin in corneal epithelial cells: Tissue-specific nuclear transport and protection from UV-damage. Prog Retin Eye Res 2005; 24(2): 139–159.
  • Wang H, Kochevar IE. Involvement of UVB-induced reactive oxygen species in TGF-beta biosynthesis and activation in keratinocytes. Free Radic Biol Med 2005; 38(7): 890–897.
  • Krutmann J. The interaction of UVA and UVB wavebands with particular emphasis on signaling. Prog Biophys Mol Biol 2006; 92: 105–107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.